CoChat

Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial.

Navari, Rudolph M., Brenner, Marie C. · 2010 · Supportive Care in Cancer

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Purpose The purpose of the study was to determine the effectiveness of megestrol acetate (MA) and olanzapine (OLN) for the treatment of cancer-related anorexia (CRA). Methods Eighty adult patients with advanced gastrointestinal cancer or lung cancer (stages III and IV) with CRA (loss of appetite and greater than or equal to 5% loss of preillness stable weight) were randomized to receive daily MA or MA plus OLN for a period of 8 weeks. Patients were assessed weekly using the M.D. Anderson Symptom Inventory with specific measurement of weight, appetite, nausea, and quality of life (QOL) measures. Results For the 37 patients receiving MA, 15 patients had a greater than or equal to 5% weight gain, 2 patients had an appetite improvement, 3 patients had an improvement in nausea, and 5 patients had an improvement in QOL at both 4 and 8 weeks. For the 39 patients receiving MA plus OLN, 33 patients had a greater than or equal to 5% weight gain, 25 patients had an appetite improvement, 21 patients had an improvement in nausea, and 23 patients had an improvement in QOL at both 4 and 8 weeks, and there was an improvement in general activity, mood, work, walking, and enjoyment at 8 weeks. There were no grade III or IV treatment-related toxicities in patients receiving MA or the combination of MA plus OLN. Conclusions The combination of MA and OLN appears to be an effective intervention for patients with CRA.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00520-009-0739-7

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. Hale AS (1997) Olanzapine. Br J Hosp Med 58:443–445

Cited by

See all 109

Metadata

Authors
Navari, R. M., & Brenner, M. C.
Affiliations
University of Notre Dame (US)
Corresponding author
Navari, Rudolph M.
Venue
Supportive Care in Cancer
Published
2009-09-11
Volume
18
Issue
8
Pages
951-956
ISSN
  • 0941-4355 (ISSN-L)
  • 1433-7339
OpenAlex
W2080945325
Cited by
99
References
21
Citations by year
2026: 3 · 2025: 4 · 2024: 14 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 3 · 2013: 5 · 2012: 14
FWCI
4.20
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Supportive Care in Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
Walther Cancer Foundation
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
cancer-related anorexia, megestrol acetate, olanzapine, combination therapy, weight gain, appetite, nausea, quality of life, gastrointestinal cancer, lung cancer, advanced cancer, symptom management
MeSH terms
Olanzapine, Adult, Aged, Aged, 80 and over, Anorexia, Appetite, Benzodiazepines, Body Weight, Drug Therapy, Combination, Female, Gastrointestinal Neoplasms, Humans, Lung Neoplasms, Male, Middle Aged, Nausea, Neoplasm Staging, Quality of Life, Selective Serotonin Reuptake Inhibitors, Appetite Stimulants, Megestrol Acetate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. https://app.cochat.ai/papers/10.1007/s00520-009-0739-7
The paper
Navari, R. M., & Brenner, M. C. (2010). Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Supportive Care in Cancer. https://doi.org/10.1007/s00520-009-0739-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.